MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Nexvet Biopharma plc Company Profile (NASDAQ:NVET)

Consensus Ratings for Nexvet Biopharma plc (NASDAQ:NVET) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $12.33 (289.99% upside)

Analysts' Ratings History for Nexvet Biopharma plc (NASDAQ:NVET)
Show:
DateFirmActionRatingPrice TargetActions
5/14/2016Credit SuisseReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/24/2015Cowen and CompanyReiterated RatingBuy$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/24/2015Piper JaffrayReiterated RatingOverweight$17.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015JMP SecuritiesInitiated CoverageOutperform$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2015Bank of AmericaInitiated CoverageBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/28/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha